The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease
Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and…Effectivity and safety of rotigotine transdermal patch on motor and cognitive dysfunctions in Parkinson’s disease with dementia and dementia with Lewy bodies
Objective: This study aimed to demonstrate effectivity and safety of rotigotine transdermal patch (RTP) on motor and cognitive dysfunctions in patients with Parkinson's disease with…J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms
Objective: To clarify the clinical manifestations of nonmotor symptoms (NMSs) and identify factors affecting NMSs and quality of life (QOL) in Japanese patients with Parkinson's…Longitudinal assessment of sleep in an incident Parkinson’s disease cohort
Objective: To evaluate subjective and objective measures of sleep disturbance in an incident PD cohort over longitudinal follow-up. Background: Sleep disturbance is widely recognised as…Sleep disordered breathing in patients of Parkinson’s disease with REM sleep behavior disorder
Objective: This prospective study was done to study the frequency and pattern of sleep disordered breathing (SDB) in patients with PD with RBD. Background: Parkinson's…Identification of premotor Parkinson’s disease
Objective: To evaluate the prevalence of and associations between potential markers of premotor Parkinson's disease (PD) and to estimate the relative risk of these markers…Sleep related disorders in subtypes of patients with Parkinson’s disease in the Tomsk region, Russia
Objective: To describe sleep related disorders (SRD) in Tremor Dominant (TD) and Akinetic Rigid (AR) patients with Parkinson's disease in (PwPD) subtypes evaluated at Movement…Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease
Objective: To investigate whether excessive daytime sleepiness (EDS) is mediated by loss of dopaminergic function by using dopaminergic specific single photon emission computed tomography (SPECT)…Investigation of driving ability to drive safely in patients with Parkinson’s disease by interview
Objective: We investigated the vehicle driving situation, clinical signs and symptoms of PD patients to obtain the information for safe driving. Background: PD neurologists are…Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study
Objective: Outcome of Rivastigmine treatment in Parkinson's disease Dementia (PDD). Effect of treatment on cognition and Neuropsychiatric symptoms. To compare clinical global impression of Clinicians…
- « Previous Page
- 1
- …
- 4
- 5
- 6